Search

Glaxosmithkline Pharmaceuticals

Sector: Healthcare | Industry: Drugs & Pharma
R 2,731.45 35.20  | 1.31% -27.60% 69.87 23,062.09
NSE Price: Mar 30, 2017 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Mar 30, 2017 2,731.45 35.20 1.31% 2,692.00 2,696.25 19,214 2,675.00 - 2,777.00
BSE Mar 30, 2017 2,722.70 35.20 1.31% 2,691.90 2,687.50 740 2,681.10 - 2,755.00
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 10,456 P/B: 11.88 NSE Code: GLAXO
52-Week Range: R 2,600.00 - 3,872.00 Dividend Yield: 1.84% BSE Code: 500660
TTM EPS: R 38.97 Book Value: R 229.18 Face Value: R 10
Price Graph
  • Biocon (NSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Glaxosmithkline Pharma -1.23 0.48 -1.16 -26.65 1.36 3.93 9.56
S&P BSE Mid Cap 15.79 2.79 17.02 34.47 25.67 17.56 10.10
S&P BSE Healthcare 3.58 -0.85 4.73 3.38 14.81 18.57 15.58
Company's return has been calculated on basis of NSE's price.
As on Mar 29, 2017
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -16.35 - -
Net Profit -20.90 - -
EPS -20.90 - -
Book Value -7.27 - -
Average
Operating Margin 21.40 24.41 29.80
Net Margin 12.64 14.27 15.66
Return on Networth 21.38 23.48 24.20
Return on Investment 32.85 35.97 36.24
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -11.61 -5.90 1.94
Operating Profit -57.89 -50.29 -56.30
Net Profit -46.43 -32.92 -50.04
EPS -46.43 -32.92 -50.04
TTM
Revenue -1.50 6.06 3.23
Operating Profit -12.07 -19.33 -17.55
Net Profit -7.30 -11.12 -11.86
EPS -7.30 -11.12 -11.86
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Glaxosmithkline Pharma 23,062.09 2,903.80 330.05 11.06 21.38 11.88 69.87
Biocon 22,779.00 3,944.60 912.70 22.28 26.83 5.03 26.94
Divi's Laboratories 16,577.19 4,060.69 1,116.20 27.01 28.57 3.22 14.85
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 13, 2014 Glaxosmithkline Pte Ltd.  Buy Off Market 20,609,774 2,533.75 522,200.15
Fund Houses invested in the stock
Fund Dec-16 Sep-16 Jun-16 Mar-16 Dec-15
Birla Sun Life Mutual Fund 1.391 1.263 1.242 1.177 1.066
UTI Mutual Fund 0.279 0.295 0.295 0.303 0.303
IDBI Mutual Fund 0.057 0.070 0.056 0.054 0.054
Tata Mutual Fund 0.024 0.024 0.055 0.059 0.059
Reliance Mutual Fund 0.004 - 0.001 0.001 0.001
ICICI Prudential Mutual Fund 0.002 0.002 0.001 0.001 0.002
LIC Mutual Fund 0.002 0.002 0.002 0.002 -
IDFC Mutual Fund NA 0.012 0.012 0.012 -
Edelweiss Mutual Fund NA 0.011 0.022 0.030 0.013
Goldman Sachs Mutual Fund NA 0.005 0.005 0.005 0.005
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Glaxosmithkline Pharmaceuticals Ltd.

Address: Dr Annie Besant Road, Worli, Mumbai, Maharashtra - 400030 | Phone: 022-24959595 | Fax: 022-24959494

Email: [email protected]

Website: www.gsk-india.com

Registrar & Transfer Agent: Karvy Computershare Pvt Ltd

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
12.80
Piotroski F-Score
4
Modified C-Score
5
5-Years Price to Earnings
68.97
5-Years Price to Book
11.88
Earnings Yield
EBIT / Enterprise value
2.35%
PEG
Price / Earnings to growth ratio
-13.32
Related Stocks
  Current Price   Chng %
Abbott India R4,560.00 -0.46%
Ajanta Pharma R1,754.40 -1.15%
Alembic Pharmaceuticals R606.90 +2.49%
Biocon R1,139.05 -0.99%
Divi's Laboratories R622.95 -0.61%
Fortis Healthcare (India) R180.50 +1.15%
Jubilant Life Sciences R800.75 -0.02%
Natco Pharma R830.40 +2.84%
Strides Shasun R1,103.80 -1.05%
Syngene International R526.70 +0.39%
As on Mar 30, 2017